Pharmaceutical News and Articles

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Novavax, Inc. (Nasdaq NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced the Novavax COVID-19 Vaccine, Adjuvan

New Pooled Analysis Published in The Lancet Demonstrated Reduced Risk of Combined CV Death or Worsening Heart Failure with Semaglutide

Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure with mildly reduced ejection fraction or heart failure with

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

PASADENA, Calif. (BUSINESS WIRE) Sep. 2, 2024 Arrowhead Pharmaceuticals, Inc. (NASDAQ ARWR) today announced results from the Phase 3 PALISADE study of investiga

FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN

Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication

Johnson & Johnson Seeks First Approval of Nipocalimab to Treat Broadest Population Living with Antibody Positive Generalized Myasthenia Gravis

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

What Is the EEE Mosquito-Borne Virus?

New England is on alert following one death and a handful of infections of eastern equine encephalitis (EEE) virus. A New Hampshire resident died after contract

False-Positive Mammogram Result Has Many Women Quitting Mammography

A significant number of women stop getting regular mammograms after being frightened by a false positive scan that incorrectly suggests they have breast cancer,